| Myths and misconceptions about chronic constipation SA Müller-Lissner, MA Kamm, C Scarpignato, A Wald Official journal of the American College of Gastroenterology| ACG 100 (1 …, 2005 | 766 | 2005 |
| The burden of constipation on quality of life: results of a multinational survey A Wald, C Scarpignato, MA Kamm, S Mueller‐Lissner, I Helfrich, C Schuijt, ... Alimentary pharmacology & therapeutics 26 (2), 227-236, 2007 | 496 | 2007 |
| Caustic injury of the upper gastrointestinal tract: a comprehensive review S Contini, C Scarpignato World journal of gastroenterology: WJG 19 (25), 3918, 2013 | 466 | 2013 |
| Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs I Bjarnason, C Scarpignato, E Holmgren, M Olszewski, KD Rainsford, ... Gastroenterology 154 (3), 500-514, 2018 | 460 | 2018 |
| Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy L Gatta, N Vakil, D Vaira, C Scarpignato Bmj 347, 2013 | 385 | 2013 |
| Effective and safe proton pump inhibitor therapy in acid-related diseases–a position paper addressing benefits and potential harms of acid suppression C Scarpignato, L Gatta, A Zullo, C Blandizzi, ... BMC medicine 14, 1-35, 2016 | 379 | 2016 |
| A multinational survey of prevalence and patterns of laxative use among adults with self‐defined constipation A Wald, C Scarpignato, S Mueller‐Lissner, MA Kamm, U Hinkel, I Helfrich, ... Alimentary pharmacology & therapeutics 28 (7), 917-930, 2008 | 355 | 2008 |
| Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention C Scarpignato, RH Hunt Gastroenterology Clinics 39 (3), 433-464, 2010 | 338 | 2010 |
| Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential C Scarpignato, I Pelosini Chemotherapy 51 (Suppl. 1), 36-66, 2005 | 335 | 2005 |
| Reflux related symptoms in patients with normal oesophageal exposure to acid. G Shi, SB Des Varannes, C Scarpignato, M Le Rhun, JP Galmiche Gut 37 (4), 457-464, 1995 | 313 | 1995 |
| Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis–an expert consensus addressing benefits as well as gastrointestinal and cardiovascular … C Scarpignato, A Lanas, C Blandizzi, WF Lems, M Hermann, RH Hunt, ... BMC medicine 13, 1-22, 2015 | 301 | 2015 |
| Proton pump inhibitors in GORD: an overview of their pharmacology, efficacy and safety V Savarino, F Di Mario, C Scarpignato Pharmacological Research 59 (3), 135-153, 2009 | 276 | 2009 |
| Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth L Gatta, C Scarpignato, RW McCallum, L Lombardo, M Pimentel, R D'Incà, ... Alimentary pharmacology & therapeutics 45 (5), 604-616, 2017 | 257 | 2017 |
| Italian consensus conference for colonic diverticulosis and diverticular disease R Cuomo, G Barbara, F Pace, V Annese, G Bassotti, GA Binda, T Casetti, ... United European gastroenterology journal 2 (5), 413-442, 2014 | 229 | 2014 |
| Action of caerulein on gastric emptying of the conscious rat. C Scarpignato, T Capovilla, G Bertaccini Archives Internationales de Pharmacodynamie et de Therapie 246 (2), 286-294, 1980 | 211 | 1980 |
| Colonic diverticular disease A Tursi, C Scarpignato, LL Strate, A Lanas, W Kruis, A Lahat, S Danese Nature Reviews Disease Primers 6 (1), 20, 2020 | 205 | 2020 |
| The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel G Burmester, A Lanas, L Biasucci, M Hermann, S Lohmander, I Olivieri, ... Annals of the rheumatic diseases 70 (5), 818-822, 2011 | 191 | 2011 |
| Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic C Scarpignato, I Pelosini Digestion 73 (Suppl. 1), 13-27, 2006 | 168 | 2006 |
| COVID-19 and gastrointestinal disease: implications for the gastroenterologist RH Hunt, JE East, A Lanas, P Malfertheiner, J Satsangi, C Scarpignato, ... Digestive Diseases 39 (2), 119-139, 2021 | 166 | 2021 |
| Acid suppression therapy: where do we go from here? C Scarpignato, I Pelosini, F Di Mario Digestive Diseases 24 (1-2), 11-46, 2006 | 164 | 2006 |
